Page 83 - GPD-3-3

Gene & Protein in Disease

PERSPECTIVE ARTICLE
Exploring the frontiers of genetics and genomics

in the digital era

1,2
Marco Crimi * , Francesca Ronzoni , Alison Masiel Magne Jimenes , and
1
1
Emil Byberg 2
1 Biomed Research Office, Kaleidos SCS, Bergamo, Italy
2 R&D Office, Net-Medicare SRL, Bergamo, Italy

Abstract
Genetics provides a vital tool for primary health-care practitioners, aiding in targeted
medication therapy, managing multifactorial illness risks, and addressing hereditary
reproductive hazards. Discovering genomic variations linked to diseases enhances
our understanding of these medical conditions, facilitating the development of
personalized treatments and influencing health-care decisions. It has been predicted
that advancing technologies and research will improve clinical practices. For instance,
the post-COVID-19 era saw the increasing fusion of genetic approaches with digital
health tools, marked by the incorporation of genetic data into electronic medical
records, which helps advance the maturation of precision medicine. However,
challenges such as managing large datasets and limited resource accessibility hinder
the full potential of genetic data. Standardizing data formats and integrating genetic
data with health-care systems remains problematic and unfeasible for collaboration.
The rise of telemedicine and remote monitoring has paved the way for more expanded
genetic counseling access, whereas artificial intelligence provides a promising tool
*Corresponding author: for revolutionizing precision medicine through extensive genomic data analysis.
Marco Crimi
(mcrimi@kaleidos.care) Nonetheless, privacy, standardization, and ethical concerns persist, calling for more
secure data management practices in genomic health care. Ensuring compliance
Citation: Crimi M, Ronzoni F,
Jimenes AMM, Byberg E. Exploring with the General Data Protection Regulation and Health Insurance Portability and
the frontiers of genetics and Accountability Act is crucial for ethical data handling. Moreover, a shortage of trained
genomics in the digital era. Gene professionals limits access to specialized care, especially in underserved areas. This
Protein Dis. 2024;3(3):4128.
doi: 10.36922/gpd.4128 study reviews digital health applications in genetics and genomics, assessing their
impact on health-care delivery and patient outcomes. Addressing these challenges
Received: July 2, 2024 is critical for fostering effective, equitable health-care solutions, a prerequisite for
Accepted: July 29, 2024
Published Online: September 10, promoting a precise, patient-centered approach to medicine.
2024
Copyright: © 2024 Author(s). Keywords: Digital genomics; Genetic medicine; Rare diseases; Telemedicine; Genetic
This is an Open-Access article
distributed under the terms of the counseling
Creative Commons Attribution
License, permitting distribution,
and reproduction in any medium,
provided the original work is
properly cited. 1. Introduction
Publisher’s Note: AccScience At the forefront of digital health, genomics marks a significant convergence between
Publishing remains neutral with genetics and digital medicine. This integration is driven by the need to assist patients in
regard to jurisdictional claims in
published maps and institutional making informed decisions, counter the shortage of geneticists and other professionals,
affiliations. enhance health literacy, and establish interoperability measures, possibly by application

Volume 3 Issue 3 (2024) 1 doi: 10.36922/gpd.4128